DE69625813D1 - Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast - Google Patents

Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast

Info

Publication number
DE69625813D1
DE69625813D1 DE69625813T DE69625813T DE69625813D1 DE 69625813 D1 DE69625813 D1 DE 69625813D1 DE 69625813 T DE69625813 T DE 69625813T DE 69625813 T DE69625813 T DE 69625813T DE 69625813 D1 DE69625813 D1 DE 69625813D1
Authority
DE
Germany
Prior art keywords
pranlukast
granula
producing
adhesiveness
containing granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69625813T
Other languages
English (en)
Other versions
DE69625813T2 (de
Inventor
Seiei Sasatani
Masashi Shiota
Yoshinori Ii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69625813D1 publication Critical patent/DE69625813D1/de
Publication of DE69625813T2 publication Critical patent/DE69625813T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69625813T 1995-06-12 1996-06-11 Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast Expired - Fee Related DE69625813T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16929295 1995-06-12
PCT/JP1996/001578 WO1996041628A1 (fr) 1995-06-12 1996-06-11 Granules contenant du pranlukast, procede de production des granules et procede de reduction de la cohesion du pranlukast

Publications (2)

Publication Number Publication Date
DE69625813D1 true DE69625813D1 (de) 2003-02-20
DE69625813T2 DE69625813T2 (de) 2003-09-04

Family

ID=15883819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625813T Expired - Fee Related DE69625813T2 (de) 1995-06-12 1996-06-11 Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast

Country Status (8)

Country Link
US (1) US5876760A (de)
EP (1) EP0834314B1 (de)
KR (1) KR100389606B1 (de)
AT (1) ATE230987T1 (de)
DE (1) DE69625813T2 (de)
DK (1) DK0834314T3 (de)
ES (1) ES2191101T3 (de)
WO (1) WO1996041628A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19617487A1 (de) † 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
PL343491A1 (en) * 1998-04-18 2001-08-27 Glaxo Group Ltd Pharmaceutical aerosol formulation
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
KR100381834B1 (ko) * 2000-05-20 2003-04-26 이상득 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법
US6692976B1 (en) * 2000-08-31 2004-02-17 Agilent Technologies, Inc. Post-etch cleaning treatment
WO2006019874A1 (en) * 2004-07-14 2006-02-23 Inflammation Research Center Company Ltd. Method for inhibiting tumor metastasis
KR100591786B1 (ko) 2004-10-19 2006-06-26 휴먼팜 주식회사 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법
KR101086254B1 (ko) * 2004-11-04 2011-11-24 에스케이케미칼주식회사 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법
KR20100034057A (ko) * 2005-04-11 2010-03-31 오노 야꾸힝 고교 가부시키가이샤 쓴맛이 저감된 프란루카스트 수화물을 함유하는 제제
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
KR101233235B1 (ko) * 2005-08-26 2013-02-15 에스케이케미칼주식회사 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법
KR100715355B1 (ko) 2005-09-30 2007-05-07 주식회사유한양행 프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법
KR100981750B1 (ko) * 2005-10-28 2010-09-10 주식회사유한양행 분무-건조 과립 및 그의 제조방법
KR100981751B1 (ko) * 2005-10-28 2010-09-10 주식회사유한양행 프란루카스트를 함유하는 과립 및 그의 제조방법
RU2461382C2 (ru) * 2006-12-22 2012-09-20 Юхан Корпорейшн Содержащая ревапразан твердая дисперсия и способ ее получения
KR102363727B1 (ko) * 2015-06-01 2022-02-16 삼아제약 주식회사 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법
CN116270902B (zh) * 2023-04-26 2024-08-20 南京同仁堂药业有限责任公司 一种颈舒颗粒及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
WO1993017709A1 (en) * 1992-03-12 1993-09-16 Ono Pharmaceutical Co., Ltd. Antipruritic
JPH0776516A (ja) * 1993-09-06 1995-03-20 Toyobo Co Ltd 難溶性薬物含有製剤の製造方法

Also Published As

Publication number Publication date
DE69625813T2 (de) 2003-09-04
DK0834314T3 (da) 2003-02-24
KR19990022791A (ko) 1999-03-25
EP0834314B1 (de) 2003-01-15
EP0834314A1 (de) 1998-04-08
EP0834314A4 (de) 2000-05-10
ATE230987T1 (de) 2003-02-15
WO1996041628A1 (fr) 1996-12-27
US5876760A (en) 1999-03-02
KR100389606B1 (ko) 2003-09-26
ES2191101T3 (es) 2003-09-01

Similar Documents

Publication Publication Date Title
ATE230987T1 (de) Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
PT797987E (pt) Preparacao granular de libertacao controlada e processo para a sua preparacao
TW367363B (en) Production of anionic surfactant granules
ATE323467T1 (de) Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
MY105047A (en) Process for making concentrated surfactant granules.
CA2268626A1 (en) Pharmaceutical composition for rapid suspension in aqueous media
DE50001620D1 (de) Verfahren zur herstellung von perlpolymerisaten
CA2430197A1 (en) Polymerization process
DE69614088D1 (de) Verfahren zur Herstellung von Schokolade und ähnliche Erzeugnisse
ATE195001T1 (de) Herstellung und verwendung von diacylperoxid enthaltende kompositteilchen
HUP0003095A2 (hu) Tabletta alakú mosószer összesajtolt szemcsékből, valamint eljárás előállítására
ATE106090T1 (de) Verfahren zur herstellung von polymeren auf der basis von styrol und katalysator zur verwendung bei diesem verfahren.
DE60133882D1 (de) Mutante bakteriestämme vom genus sphingonomas die defizient in der herstellung von polyhydroxybutyrate sind, und verfahren zur klärung von sphinganen
NO894689D0 (no) Fremgangsmaate for fremstilling av blekende granulat.
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
DE69911181D1 (de) Verfahren zur herstellung von partikeln aus nano-dimenzion material
MX9801940A (es) Composiciones que comprenden particulas de silice hidrofilica.
DE59801861D1 (de) Verfahren zur herstellung von waschmittelrohstoffen
DE59206997D1 (de) Verfahren zur herstellung eines knöllchenförmigen produktes
HU9601321D0 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them
IE892100L (en) Process for making concentrated surfactant granules
CA2071707A1 (en) Polymer Alloy Material and Process for Production Thereof
EP0162465A3 (de) Verbindungen verwendet in Parfüms
ATE197811T1 (de) Verfahren zur herstellung von rieselfähigen waschmittelgranulaten
FR2689502B1 (fr) Procédé de production de 1, 1-dichloro-1-fluoréthane ("141b") stabilisé et produit obtenu.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee